Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort

CONCLUSION: With nearly 100% DAA treatment success and a low reinfection rate, treatment uptake directly translates into a reduction of HCV-RNA prevalence. Eighty percent treatment uptake is feasible in OAT patients, and adherence and treatment success are not worse than in other populations. Duration of infectiousness and thus HCV transmission can be reduced by early detection and treatment of chronic hepatitis C.PMID:33705563 | DOI:10.4414/smw.2021.20460

Source: Swiss Medical Weekly - March 11, 2021 Category: General Medicine Authors: Andrea Bregenzer Philip Bruggmann Erika Castro Alberto Moriggia Madeleine Rothen Maria Christine Thurnheer Pietro Vernazza Claude Scheidegger Source Type: research